You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Volume IV (bound as two volumes) provides a critical and descriptive bibliography of religion in American life that is unequalled in any other source. Arranged topically, so that books and articles on a single subject are discussed in relation to each other, and carefully cross-referenced and indexed, it will be an indispensable tool for anyone exploring further into American religion or related subjects. Originally published in 1961. The Princeton Legacy Library uses the latest print-on-demand technology to again make available previously out-of-print books from the distinguished backlist of Princeton University Press. These editions preserve the original texts of these important books while presenting them in durable paperback and hardcover editions. The goal of the Princeton Legacy Library is to vastly increase access to the rich scholarly heritage found in the thousands of books published by Princeton University Press since its founding in 1905.
Collection of primary documents, secondary reference sources, and journal articles covering all areas of U.S. history from pre-colonial times to the present day. The DAB records the lives of prominent Americans who died by Dec. 31, 1980.
Part of an integrated online collection of primary documents, secondary reference sources, and journal articles covering all areas of U.S. history from pre-colonial times to the present day. The DAB records the lives of prominent Americans who died by Dec. 31, 1980.
None
Genetic diseases and disorders are common factors in modern pharmacogenomics. The study of emerging factors in epigenomics are significant for effective drug discovery and formulation, as well as for balancing pharmacological and ethical factors in drug development. The goal of drug discovery is to recognize the new molecular formulations impactful in the treatment of genetic diseases. Further exploration of the move from preclinical drug research to the clinical stage may reveal critical transformations to provide effective medicinal products in the market. As precision medicine evolves, genomics-driven drug discovery may also improve patient outcomes while reducing the trial-and-error appr...